Search
for
Sort by
Research 841–870 of 1000+
- Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
- Management of Hirsutism
- Pathophysiology of the Behçet's Disease
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- Guidelines for the prevention of lower extremity arterial ulcers
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Trailing the Path to Preventive Oncology
- New aspects of vitamin D metabolism and action — addressing the skin as source and target
- On the effects of testosterone on brain behavioral functions
- The human skin as a hormone target and an endocrine gland
- Skin Pigmentation Types, Causes and Treatment—A Review
- Intracrine androgen biosynthesis, metabolism and action revisited
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Hormonal Therapies for Individuals with Intersex Conditions
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- The Effect of the Aqueous Extract of Bidens Pilosa L. on Androgen Deficiency Dry Eye in Rats
- Cause of Androgenic Alopecia
- Impact of Trigonella foenum-graecum Leaves Extract on Mice Hair Growth
- Is increased constitutive skin and hair pigmentation an early sign of puberty?
- Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis
- Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males?
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- The effect of vitamin D on the hormonal profile of women with polycystic ovarian syndrome: a systematic review and meta-analysis